Volume 91 Issue 47 | p. 6 | News of The Week
Issue Date: November 25, 2013 | Web Date: November 22, 2013

Pharma Services Firm Debuts

Merger: Deal marries DSM, Patheon to create manufacturing and formulation giant
Department: Business
Keywords: pharmaceuticals, contract manufacturing, formulation, fine chemicals

DSM is joining with the New York City-based private equity firm JLL Partners to create NewCo, a drug manufacturing business that will have an estimated $2 billion in annual sales. The new firm—the name is said to be only temporary—will combine DSM’s pharmaceutical services business with the Canadian formulation specialist Patheon, which is 56% owned by JLL.

DSM is contributing its active ingredients and intermediates manufacturing business for a 49% . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society